Abstract
Since the original identification of cytoplasmic estrogen receptors (ER) in human breast cancer (Jensen et al., 1971), rapid progress has been made towards linking presence of the receptor with endocrine responsiveness of the tumor. It is now known that the likelihood of a successful response to endocrine therapy is increased at least tenfold in patients whose tumors are positive for ER (ER+) (McGuire et al., 1975). However, not all ER-containing tumors respond, and this has led to the concept that ER are necessary but not sufficient markers of hormone dependence. We have demonstrated progesterone receptors (PgR) in human breast tumors (Horwitz et al., 1975a) and have proposed that this receptor, whose synthesis is known to be controlled by estrogen in the uterus, might serve as a marker of estrogen action in breast cancer (Horwitz et al., 1975b). Thus, the presence of PgR in a tumor would indicate that the entire sequence involving estrogen binding to cytoplasmic receptor, movement of the receptor complex into the nucleus, and stimulation of a specific end product can be achieved in the tumor cell, and would rule out the existence of a defect beyond the binding step. Though this proposal assumes that PgR are under control of estrogen acting through ER, this priming effect had not been demonstrated in human breast cancer. We have used the MCF-7 human breast cancer cell line to study the response of PgR to estrogens and antiestrogens. The MCF-7 cell line, derived from a patient with metastatic breast cancer (Soule et al., 1973), is ideally suited to study the mechanism of PgR induction. These cells are in permanent tissue culture, contain ER (Brooks et al., 1973; Horwitz et al., 1975a), and are estrogen-responsive (Lippman et al., 1976).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anderson, J. N., Peck, E. J., Jr., Clark, J. H.: Estrogen induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei. Endocrinology 96, 160–167 (1975)
Bastos, R. N., Aviv, H.: Globin RNA precursor molecules: biosynthesis and processing of erythroid cells. Cell 11, 641–650 (1977)
Bayard, F., Damilano, S., Robel, P., Baulieu, E. E.: Recepteurs de l’oestradiol et de la progesterone dans l’endometre humain au cours du cycle menstruel. C. R. Acad. Sci. [D] (Paris) 281, 1341–1344 (1975)
Brooks, S. C., Locke, E. R., Soule, H. D.: Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J. Biol. Chem. 248, 6251–6253 (1973)
Capony, F., Rochefort, H.: In vivo effect of antiestrogens on the localization and replenishment of ER. Mol. Cell. Endocrinol. 3, 233–251 (1975)
Cidlowski, J. A., Muldoon, T. G.: Dissimilar effects of antiestrogens upon estrogen receptors in responsive tissues of male and female rats. Biol. Reprod. 15, 381–398 (1976)
Clark, J. H., Peck, E. J., Jr.: Nuclear retention of receptor-oestrogen complex and nuclear acceptor sites. Nature 260, 635–637 (1976)
Clark, J. H., Anderson, J. N., Peck, E. J., Jr.: Estrogen receptor antiestrogen complex: atypical binding by uterine nuclei and effect on uterine growth. Steroids 22, 707–718 (1973)
Clark, J. H., Peck, E. J., Jr., Anderson, J. N.: Oestrogen receptors and antagonism of steroid hormone action. Nature 251, 446–448 (1974)
DeHertogh, R., Ekka, E., Vanderheyden, I., Hoet, J. J.: “Unbound” ligand adsorption on dextran-coated charcoal: practical considerations. J. Steroid Biochem. 4, 313–320 (1973)
Faber, L. E., Sandmann, M. L., Stavely, H. E.: Progesterone binding proteins of the rat and rabbit uterus. J. Biol. Chem. 247, 5648–5649 (1972)
Ferguson, E. R., Katzenellenbogen, B. S.: A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels. Endocrinology 100, 1242–1251 (1977)
Giannopoulos, G., Gorski, J.: Estrogen receptors-quantitative studies on transfer of estradiol from cytoplasmic to nuclear binding sites. J. Biol. Chem. 246, 2524–2529 (1971)
Goldberg, I. H., Friedman, P. A.: Antibiotics and nucleic acids. Ann. Rev. Biochem. 40, 775–810 (1971)
Hardin, J. W., Clark, J. H., Glasser, S. R., Peck, E. J., Jr.: RNA polymerase activity and uterine growth: differential stimulation by estradiol, estriol and nafoxidine. Biochemistry 15, 1370–1374 (1976)
Horwitz, K. B., McGuire, W. L.: Progesterone and progesterone receptors in experimental breast cancer. Cancer Res. 37, 1733–1738 (1977)
Horwitz, K. B., McGuire, W. L.: Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253, 2223–2228 (1978a)
Horwitz, K. B., McGuire, W. L.: Nuclear mechanisms of estrogen action: effects of estradiol and antiestrogens on estrogen receptors and nuclear receptor processing. J. Biol. Chem. 253, 8185–8191 (1978)
Horwitz, K. B., McGuire, W. L.: Actinomycin D prevents nuclear processing of estrogen receptor. J. Biol. Chem. 253, 6319–6322 (1978)
Horwitz, K. B., Costlow, M. E., McGuire, W. L.: MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone and glucocorticoid receptors. Steroids 26, 785–795 (1975a)
Horwitz, K. B., McGuire, W. L., Pearson, O. H., Segaloff, A.: Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189, 726–727 (1975b)
Horwitz, K. B., Koseki, Y., McGuire, W. L.: Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 103, 1742–1751 (1978)
Jensen, E. V., Block, G. E., Smith, S., Kyser, K., DeSombre, E. R.: ER and breast cancer response to adrenalectomy. Natl. Cancer Inst. Monogr. 34, 55–79 (1971)
Juliano, J. V., Stancel, G. H.: Estrogen receptors in the rat uterus. Retention of hormone-receptor complexes. Biochemistry 15, 916–920 (1976)
Katzenellenbogen, B. S., Ferguson, E. R.: Estrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen. Endocrinology 97, 1–12 (1975)
Katzenellenbogen, B. S., Ferguson, E. R., Lan, N. C.: Fundamental differences in the action of estrogens and antiestrogens on the uterus: comparison between compounds with similar duration of action. Endocrinology 100, 1252–1259 (1977)
Kleiman, L., Huang, R. C. C.: Binding of actinomycin D to calf thymus chromatin. J. Mol. Biol. 55, 503–521 (1971)
Lan, N. C., Katzenellenbogen, B. S.: Temporal relationships between hormone receptor binding and biological responses in the uterus: studies with short- and long-acting derivatives of estriol. Endocrinology 98, 220–227 (1976)
Lazier, C. B., Alford, W. S.: Interaction of the anti-oestrogen nafoxidine hydrochloride with the soluble nuclear oestradiol-binding protein in chick liver. Biochem. J. 164, 659–667 (1977)
Leavitt, W. W., Chen, T. J., Allen, T. C.: Regulation of progesterone receptor formation by estrogen action. Ann. N.Y. Acad. Sci. 286, 210–225 (1977)
Leinwald, L., Ruddle, F. H.: Stimulation of in vitro translation of messenger RNA by actinomycin D. Science 197, 381–383 (1977)
Lippman, M., Bolan, G., Huff, K.: Human breast cancer responsive to androgen in long term tissue culture. Cancer Res. 36, 4595–4601 (1976)
McGuire, W. L., Carbone, P. P., Sears, M. E., Escher, G. C.: Estrogen receptors: an overview. In: Estrogen receptors in human breast cancer. McGuire, W. L., Carbone, P. P., Vollmer, E. P. (eds.), p. 1. New York: Raven Press 1975
Mester, J., Baulieu, E. E.: Dynamics of oestrogen-receptor distribution between the cytosol and nuclear fraction of immature rat uterus after oestradiol administration. Biochem. J. 146, 617–623 (1975)
Palmiter, R. D., Moore, P. B., Mulvihill, E. R., Emtage, S.: A significant lag in the induction of ovalbumin messenger RNA by steroid hormones: A receptor translocation hypothesis. Cell 8, 557–572 (1976)
Ruh, T. S., Baudendistel, L. J.: Different nuclear binding sites for antiestrogen and estrogen receptor complexes. Endocrinology 100, 420–426 (1977)
Sarff, M., Gorski, J.: Control of estrogen binding protein concentration under basal conditions and after estrogen administration. Biochemistry 10, 2557–2563 (1971)
Sehrader, W. T., Toft, D. O., O’Malley, B. W.: Progesterone binding protein of chick oviduct. VI. Interaction of purified progesterone receptor components with nuclear constituents. J. Biol. Chem. 247, 2401–2407 (1972)
Sherman, M. R., Corval, P. I., O’Malley, B. W.: Progesterone binding components of chick oviduct. J. Biol. Chem. 245, 6085–6096 (1970)
Sobel, H. M., Jain, S. C.: Stereochemistry of actinomycin binding to DNA: II. Detailed molecular model of actinomycin-DNA complex and its implications. J. Mol. Biol. 68, 21–34 (1972)
Sonnenschein, C., Soto, A. M., Cologiore, J., Farookhi, R.: Estrogen target cells. Establishment of a cell line derived from rat pituitary tumor MtT/F4. Exp. Cell Res. 101, 15–22 (1976)
Soule, H. D., Vasquez, J., Long, A., Albert, S., Brennan, M. J.: A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409–1416 (1973)
Stormshak, F., Leake, R., Wertz, N., Gorski, J.: Stimulatory and inhibitory effects of estrogen on uterine DNA synthesis. Endocrinology 99, 1501–1511 (1976)
Williams, D., Gorski, J.: Kinetic and equilibrium analysis of estradiol in uterus: a model of binding site distribution in uterine cells. Proc. Natl. Acad. Sci. USA 69, 3464–3468 (1972)
Zava, D. T., McGuire, W. L.: Estrogen receptor. Unoccupied sites in nuclei of a breast tumor cell line. J. Biol. Chem. 252, 3703–3708 (1977)
Zava, D. T., Chamness, G. C., Horwitz, K. B., McGuire, W. L.: Human breast cancer: Biologically achieve estrogen receptor in the absence of estrogen? Science 197, 663–664 (1977)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Horwitz, K.B., McGuire, W.L. (1980). Studies on Mechanisms of Estrogen and Antiestrogen Action in Human Breast Cancer. In: Henningsen, B., Linder, F., Steichele, C. (eds) Endocrine Treatment of Breast Cancer. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 71. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81406-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-81406-8_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81408-2
Online ISBN: 978-3-642-81406-8
eBook Packages: Springer Book Archive